Additionally, I-BET 762 demonstrated the ability to reduce c-Myc and p-Erk 1/2 protein levels, inhibit cancer cell proliferation, and suppress the generation of multiple inflammatory cytokines (Leal et al., 2017). Here, MYC is linked to cancer.